Intestinal interleukin-13 in pediatric inflammatory bowel disease patients

Inflammatory Bowel Diseases

Volumn 10, Issue 5, 2004, Pages 593-598

  Kadivar, Khadijeh ^a   Ruchelli, Eduardo D ^a   Markowitz, Jonathan E ^a,b   DeFelice, Magee L ^a   Strogatz, Melissa L ^a   Kanzaria, Mitul M ^a   Reddy, Krishna P ^a   Baldassano, Robert N ^a   von Allmen, Daniel ^a   Brown, Kurt A ^a,b,c  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c ASTRAZENECA   (United Kingdom)

Author keywords

Inflammatory bowel disease; Interleukin 13; Intestine; Pediatric

Indexed keywords

INTERLEUKIN 13; INTERLEUKIN 1BETA; INTERLEUKIN 6;

ARTICLE; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; COLON RESECTION; CONTROLLED STUDY; CORRELATION FUNCTION; CROHN DISEASE; CYTOKINE PRODUCTION; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; DISEASE SEVERITY; ENTERITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTESTINE BIOPSY; INTESTINE ENDOSCOPY; INTESTINE SURGERY; LAMINA PROPRIA; ORGAN CULTURE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; STATISTICAL SIGNIFICANCE; SUPERNATANT; ULCERATIVE COLITIS;

ADOLESCENT; CHILD; DISEASE PROGRESSION; ENDOSCOPY; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INFLAMMATORY BOWEL DISEASES; INTERLEUKIN-13; MALE;

EID: 4644345071     PISSN: 10780998     EISSN: None     Source Type: Journal    
DOI: 10.1097/00054725-200409000-00014     Document Type: Article

References (23)

1. Sartor RB. Cytokines in intestinal inflammation: pathophysiological and clinical considerations. Gastroenterology. 1994;106:533-539.
2. Niessner M, Volk BA. Altered Th1/Th2 cytokine profiles in the intestinal mucosa of patients with inflammatory bowel disease as assessed by quantitative reversed transcribed polymerase chain reaction (RT-PCR). Clin Exp Immunol. 1995;101:428-435.
3. de Waal MR, Figdor CG, Huijbens R, et al. Effects of IL-13 on phenotype, cytokine production, and cytotoxic function of human monocytes. Comparison with IL-4 and modulation by IFN- gamma or IL-10. J Immunol. 1993;151:6370-6381.
4. Hart PH, Ahern MJ, Smith MD, et al. Regulatory effects of IL-13 on synovial fluid macrophages and blood monocytes from patients with inflammatory arthritis. Clin Exp Immunol. 1995;99:331-337.
5. Tan J, Deleuran B, Gesser B, et al. Regulation of human T lymphocyte chemotaxis in vitro by T cell-derived cytokines IL-2, IFN-gamma, IL-4, IL-10 and IL-13. J Immunol. 1995;154:3742-3752.
6. Kucharzik T, Lugering N, Weigelt H, et al. Immunoregulatory properties of IL-13 in patients with inflammatory bowel disease; comparison with IL-4 and IL-10. Clin Exp Immunol. 1996;104:483-490.
7. Quiding M, Nordstrom I, Kilander A, et al. Intestinal immune responses in humans. Oral cholera vaccination induces strong intestinal antibody responses and interferon-gamma production and evokes local immunological memory. J Clin Invest. 1991;88:143-148.
8. Vainer B, Nielsen OH, Hendel J, et al. Colonic expression and synthesis of interleukin 13 and interleukin 15 in inflammatory bowel disease. Clytokine. 2000;12:1531-1536.
9. Mazlam MZ, Hodgson HJ. Peripheral blood monocyte cytokine production and acute phase response in inflammatory bowel disease. Gut. 1992; 33:773-778.
10. Isaacs KL, Sartor RB, Haskill S. Cytokine messenger RNA profiles in inflammatory bowel disease mucosa detected by polymerase chain reaction amplification. Gastroenterology. 1992;103:1587-1595.
11. Kolios G, Rooney N, Murphy CT, et al. Expression of inducible nitric oxide synthase activity in human colon epithelial cells: modulation by T lymphocyte derived cytokines. Gut. 1998;43:56-63.
12. Nakamura M, Saito H, Kasanuki J, et al. Cytokine production in patients with inflammatory bowel disease. Gut. 1992;33:933-937.
13. Desreumaux P, Brandt E, Gambiez L, et al. Distinct cytokine patterns in early and chronic ileal lesions of Crohn's disease. Gastroenterology. 1997;113:118-126.
14. Brown K, Kriss J, Moser C, et al. Circulating rotavirus-specific antibody-secreting cells (ASC) predict the presence of rotavirus-specific ASC in the human small intestinal lamina propria. J Infect Dis. 2000;182:1039-1043.
15. Kucharzik T, Lugering N, Adolf M, et al. Synergistic effect of immunoregulatory cytokines on peripheral blood monocytes from patients with inflammatory bowel disease. Dig Dis Sci. 1997;42:805-812.
16. Hurst SD, Barrett TA. T-cell responses to enteric antigens. Semin Gastrointest Dis. 1996;7:118-123.
17. Salmi M, Jalkanen S. Regulation of lymphocyte traffic to mucosa-associated lymphatic tissues. Gastroenterol Clin North Am. 1991;20:495-510.
18. Heikenen JB, Werlin SL, Brown CW, et al. Presenting symptoms and diagnostic lag in children with inflammatory bowel disease. Inflamm Bowel Dis. 1999;5:158-160.
19. Ligumsky M, Kuperstein V, Nechushtan H, et al. Analysis of cytokine profile in human colonic mucosal Fc epsilonRI-positive cells by single cell PCR: inhibition of IL-3 expression in steroid-treated IBD patients. FEBS Lett. 1997;413:436-440.
20. Naseer T, Minshall EM, Leung DY, et al. Expression of IL-12 and IL-13 mRNA in asthma and their modulation in response to steroid therapy. Am J Respir Crit Care Med. 1997;155:845-851.
21. Calkins BM, Lilienfeld AM, Garland CF, et al. Trends in incidence rates of ulcerative colitis and Crohn's disease. Dig Dis Sci. 1984;29:913-920.
22. D'Andrea A, Ma X, Aste-Amezaga, et al. Stimulatory and inhibitory effects of interleukin (IL)-4 and IL-13 on the production of cytokines by human peripheral blood mononuclear cells: priming for IL-12 and tumor necrosis factor alpha production. J Exp Med. 1995;181:537-546.
23. Lugering N, Kucharzik T, Stein H, et al. IL-10 synergizes with IL-4 and IL-13 in inhibiting lysosomal enzyme secretion by human monocytes and lamina propria mononuclear cells from patients with inflammatory bowel disease. Dig Dis Sci. 1998;43:706-714.